CD4 and neoplasm: For example, SNORA38B promotes IL-10 secretion in tumor cells, leading to the recruitment of CD4+FOXP3+regulatory T cells and reduced infiltration of CD3+CD8+T cells in the TME of non-small cell lung cancer (NSCLC), thereby promoting tumor progression.